Azathioprine Combination Therapy for Steroid-Refractory Hepatic Immune System-Related Adverse Events

European Journal of Dermatology - France
doi 10.1684/ejd.2017.2973
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

John Libbey Eurotext

Related search

EL25Management of Immune-Related Adverse Events

Annals of Oncology
MedicineOncologyHematology
2018English

Immune Dysregulation in Cancer Patients Developing Immune-Related Adverse Events

British Journal of Cancer
Cancer ResearchOncology
2018English

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

New England Journal of Medicine
Medicine
2010English

Concurrent Therapy With Immune Checkpoint Inhibitors and TNFα Blockade in Patients With Gastrointestinal Immune-Related Adverse Events

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Cardiovascular Immune‐related Adverse Events: Evaluation, Diagnosis and Management

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2020English

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

JAMA Oncology
Cancer ResearchOncology
2019English

4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy